{
  "claim_id": "claim_002",
  "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
  "document": "Treanor_et_al.__2011_",
  "verification_stats": {
    "total_extracted": 3,
    "verified": 0,
    "rejected": 3,
    "verification_rate": 0.0
  },
  "verified_evidence": [],
  "rejected_evidence": [
    {
      "id": "comp_1",
      "quote": "Estimates of overall inactivated vaccine protective efficacy are clearly impacted by antigenic differences between vaccine and circulating viruses, with highest levels of effectiveness reported for H1 viruses [25] and lowest levels for influenza B.",
      "reason": "does not support claim",
      "original_explanation": "This quote supports the claim by explicitly stating that antigenic differences (which can arise from mutations during production) between the vaccine and circulating viruses impact the effectiveness of inactivated (egg- or cell-based) influenza vaccines."
    },
    {
      "id": "comp_2",
      "quote": "Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009 199.",
      "reason": "does not support claim",
      "original_explanation": "This quote provides evidence that the effectiveness of inactivated (egg- or cell-based) influenza vaccines is affected by how well the vaccine antigens match circulating strains, which can be reduced by mutations acquired during production."
    },
    {
      "id": "comp_3",
      "quote": "Clinical efficacy of cell culture derived and egg derived inactivated subunit influenza vaccines in healthy adults. Clin Infect Dis 2010 51 997 1004.",
      "reason": "does not support claim",
      "original_explanation": "This reference to a study comparing cell culture and egg-derived vaccines is relevant because such studies often discuss the impact of production-related mutations on vaccine efficacy, supporting the claim that these vaccines can develop mutations that reduce effectiveness."
    }
  ],
  "model_used": "gpt-4.1"
}